November 28, 2016 - By Adrian Mccoy
Expert analysts at RBC Capital Markets’s research division increased KP Tissue (TSE:KPT)‘s stock from a “Sector Perform” to “Outperform” on Monday morning. The analysts at RBC Capital Markets have a target price per share of $17.00 on KPT or 14.86% more upside.
Out of 4 analysts covering KP Tissue (TSE:KPT), 2 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 50% are positive. $18 is the highest target while $13.50 is the lowest. The $16.10 average target is 8.78% above today’s ($14.8) stock price. KP Tissue has been the topic of 17 analyst reports since August 13, 2015 according to StockzIntelligence Inc. The firm has “Outperform” rating given on Friday, November 4 by Scotia Capital. Scotia Capital maintained it with “Outperform” rating and $16.50 target price in Thursday, November 24 report. The firm has “Hold” rating given on Friday, October 21 by TD Securities. TD Securities maintained KP Tissue Inc (TSE:KPT) rating on Friday, August 12. TD Securities has “Buy” rating and $15 price target. The stock has “Hold” rating given by TD Securities on Friday, November 4. Scotia Capital maintained the stock with “Outperform” rating in Tuesday, September 1 report.
About 14,308 shares traded hands or 80.32% up from the average. KP Tissue Inc (TSE:KPT) has risen 11.62% since April 22, 2016 and is uptrending. It has outperformed by 5.60% the S&P500.
KP Tissue Inc. is created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. . The company has a market cap of $136.06 million. KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom tissue, facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets. It currently has negative earnings. KPLP operates through three divisions: consumer products sold through traditional retail channels, such as grocery stores, mass merchandisers, club stores, drug stores and convenience stores (Consumer); AFH, and Other.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Adrian Mccoy